Publication | Closed Access

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

Renal Transplant PatientsUrologyTransplantationKidney TransplantKidney TransplantationSolid Organ TransplantationTransplantation MedicinePharmacologyThree‐year EfficacyGraft SurvivalSafety ResultsMedicineNephrology